Zero-Cost Offer to Support the Development of COVID-19 Vaccine Technologies in NZ

In these unsettling times of the COVID-19 pandemic, we at Catalyst Intellectual Property want to support the efforts that are planned or are underway in New Zealand for the development of a COVID-19 vaccine. The development of a vaccine for COVID-19 is a priority for public health. We are all in this pandemic together, and we want to do our bit to contribute. We are especially pleased to offer our services to anyone in New Zealand at no cost for the establishment of patent protection for innovations relating to COVID-19 vaccine development. The services include the preparation (drafting of patent specifications) and filing of provisional patent applications in New Zealand. If you would like to take advantage of this offer, please get in touch with your main contact at Catalyst Intellectual Property or any of Greg Lynch (, Garth Hendry ( and John Mansell (

Recent Posts

See All

We are very pleased to welcome Ana Matsis to Catalyst Intellectual Property. Ana strengthens our capability in the area of trade marks and branding. She was previously a trade mark specialist from 19

Australia’s second-tier patent, known as the “innovation patent”, is being phased out. With a few exceptions, the final date to file an application for an Australian innovation patent is 25 August 202

The Australian Government’s Budget 2021-2022 introduces a special tax rate (a “Patent Box”) for income derived from Australian patents in the medical and biotechnology fields. From July 2022, income d